Abstract
The posttranslational modification of deimination refers to conversion of protein-bound arginine into citrulline. It is frequently detected by monoxime treatment (acid phase 2,3-butanedione and antipyrine reaction) resulting in an adduct formation. We present evidence that deiminated proteins are prone to aggregate formation upon prolonged monoxime exposure. Moreover, the efficiency of adduct formation is nonlinear and dramatically reduced with increasing polypeptide complexity [complete with smaller but progressively decreasing with higher (poly)peptides]. This nonlinearity results in vastly noncomparable detection among different methods such as immunohistochemistry, Western blot, and mass spectrometry. Mass spectrometric detection, based on mass addition of +238 on citrulline moiety with monoxime and +1 change due to deimination without monoxime treatment, corroborates serious limitations in monoxime adduct formation on proteins. Methodological limitations may also interfere with the identification of deiminated proteins as well as their modification sites and, as a consequence, the understanding of the biological role of deimination. We present here methods that alter the sequence of digestion and the combination of chromatographic techniques that collectively reduce complexity and help capture the deiminated peptides. Thin-layer chromatographic methods, together with different enzymatic digestions, can also be potentially routinely used for detection of changes in deimination sites within a given protein in different states of a cell or tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Algeciras, M. E., & Bhattacharya, S. K. (2007). Targeting optic nerve citrullination in glaucoma: A role for protein-arginine deiminase 2 (PAD2) inhibitors. Drugs of the Future, 32, 999–1006.
Archibald, R. M. (1944). Determination of citrulline and allantoin and demonstration of citrulline in blood plasma. The Journal of Biological Chemistry, 156, 121–142.
Arnold, J. N., Saldova, R., Hamid, U. M., & Rudd, P. M. (2008). Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics, 8, 3284–3293.
Bennike, T., Lauridsen, K. B., Olesen, M. K., Andersen, V., Birkelund, S., & Stenballe, A. (2013). Optimizing the identification of citrullinated peptides by mass spectrometry: Utilizing the inability of trypsin to cleave after citrullinated amino acids. Journal of Proteomics & Bioinformatics, 6, 288–295.
Bhattacharya, S. K., Sinicrope, B., Rayborn, M. E., Hollyfield, J. G., & Bonilha, V. L. (2008). Age-related reduction in retinal deimination levels in the F344BN rat. Aging Cell, 7, 441–444.
Boyde, T. R., & Rahmatullah, M. (1980). Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Analytical Biochemistry, 107, 424–431.
Bradbury, E. M. (1992). Reversible histone modifications and the chromosome cell cycle. BioEssays, 14, 9–16.
Chavanas, S., Mechin, M. C., Nachat, R., Adoue, V., Coudane, F., Serre, G., & Simon, M. (2006). Peptidylarginine deiminases and deimination in biology and pathology: Relevance to skin homeostasis. Journal of Dermatological Science, 44, 63–72.
De Ceuleneer, M., Van Steendam, K., Dhaenens, M., & Deforce, D. (2012). In vivo relevance of citrullinated proteins and the challenges in their detection. Proteomics, 12, 752–760.
Ding, D., Enriquez-Algeciras, M., Dave, K. R., Perez-Pinzon, M., & Bhattacharya, S. K. (2012). The role of deimination in ATP5b mRNA transport in a transgenic mouse model of multiple sclerosis. EMBO Reports, 13, 230–236.
Enriquez-Algeciras, M., Ding, D., Chou, T. H., Wang, J., Padgett, K. R., Porciatti, V., & Bhattacharya, S. K. (2011). Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods. Investigative Ophthalmology & Visual Science, 52, 2405–2411.
Enriquez-Algeciras, M., Ding, D., Mastronardi, F. G., Marc, R. E., Porciatti, V., & Bhattacharya, S. K. (2013). Deimination restores inner retinal visual function in murine demyelinating disease. The Journal of Clinical Investigation, 123, 646–656.
Ganesan, V., Schmidt, B., Avula, R., Cooke, D., Maggiacomo, T., Tellin, L., Ascherman, D. P., Bruchez, M. P., & Minden, J. (2015). Immuno-proteomics: Development of a novel reagent for separating antibodies from their target proteins. Biochimica et Biophysica Acta, 1854, 592–600.
Gyorgy, B., Toth, E., Tarcsa, E., Falus, A., & Buzas, E. I. (2006). Citrullination: A posttranslational modification in health and disease. The International Journal of Biochemistry & Cell Biology, 38, 1662–1677.
Harauz, G., & Musse, A. A. (2007). A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease. Neurochemical Research, 32, 137–158.
Holm, A., Rise, F., Sessler, N., Sollid, L. M., Undheim, K., & Fleckenstein, B. (2006). Specific modification of peptide-bound citrulline residues. Analytical Biochemistry, 352, 68–76.
Kubota, K., Yoneyama-Takazawa, T., & Ichikawa, K. (2005). Determination of sites citrullinated by peptidylarginine deiminase using 18O stable isotope labeling and mass spectrometry. Rapid Communications in Mass Spectrometry, 19, 683–688.
Macek, B., Mann, M., & Olsen, J. V. (2008). Global and site-specific quantitative phosphoproteomics: Principles and applications. Annual Review of Pharmacology and Toxicology, 49, 199–221.
Marletta, M. A., Hurshman, A. R., & Rusche, K. M. (1998). Catalysis by nitric oxide synthase. Current Opinion in Chemical Biology, 2, 656–663.
Mechin, M. C., Sebbag, M., Arnaud, J., Nachat, R., Foulquier, C., Adoue, V., Coudane, F., Duplan, H., Schmitt, A. M., Chavanas, S., Guerrin, M., Serre, G., & Simon, M. (2007). Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. International Journal of Cosmetic Science, 29, 147–168.
Nicholas, A. P., & Whitaker, J. N. (2002). Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain. Glia, 37, 328–336.
Nita-Lazar, A., Saito-Benz, H., & White, F. M. (2008). Quantitative phosphoproteomics by mass spectrometry: Past, present, and future. Proteomics, 8, 4433–4443.
Patel, N., Solanki, E., Picciani, R., Cavett, V., Caldwell-Busby, J. A., & Bhattacharya, S. K. (2008). Strategies to recover proteins from ocular tissues for proteomics. Proteomics, 8, 1055–1070.
Ryan, K., & Bauer, D. L. (2008). Finishing touches: Post-translational modification of protein factors involved in mammalian pre-mRNA 3′ end formation. The International Journal of Biochemistry & Cell Biology, 40, 2384–2396.
Senshu, T., Sato, T., Inoue, T., Akiyama, K., & Asaga, H. (1992). Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Analytical Biochemistry, 203, 94–100.
Sims, R. J., III, & Reinberg, D. (2008). Is there a code embedded in proteins that is based on post-translational modifications? Nature Reviews. Molecular Cell Biology, 9, 815–820.
Stuehr, D. J. (2004). Enzymes of the L-arginine to nitric oxide pathway. The Journal of Nutrition, 134, 2748S–2751S. discussion 2765S–2767S.
Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J., & Pruijn, G. J. (2003). PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. BioEssays, 25, 1106–1118.
Watanabe, K., Akiyama, K., Hikichi, K., Ohtsuka, R., Okuyama, A., & Senshu, T. (1988). Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochimica et Biophysica Acta, 966, 375–383.
Wood, D. D., & Moscarello, M. A. (1989). The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. The Journal of Biological Chemistry, 264, 5121–5127.
Zarabian, B., Koushesh, F., & Vassef, A. (1987). Modified methods for measuring citrulline and carbamoyl-beta-alanine with reduced light sensitivity and sucrose interference. Analytical Biochemistry, 166, 113–119.
Zhang, Q., & Wang, Y. (2008). High mobility group proteins and their post-translational modifications. Biochimica et Biophysica Acta, 1784, 1159–1166.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Enriquez-Algeciras, M., Ding, D., Ascherman, D.P., Bhattacharya, S.K. (2017). Chemical Modification and Mass Spectrometric Approaches for Detection of Brain Protein Deimination. In: Nicholas, A., Bhattacharya, S., Thompson, P. (eds) Protein Deimination in Human Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-58244-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-58244-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58243-6
Online ISBN: 978-3-319-58244-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)